All In Biotech

Free tool

FAERS Monitor: Nasacort Allergy 24 Hour

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 020468 or its brand name (Nasacort Allergy 24 Hour, Triamcinolone Acetonide). Reports on generic versions are filed under their own applications.

Reports

29,292

Serious

13,599

46% of reports

Hospitalization

6,385

Death reported

3,180

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • drug ineffective5,253
  • off label use2,925
  • pruritus2,760
  • rash2,607
  • pain2,187
  • fatigue2,113
  • nausea2,038
  • headache1,872
  • condition aggravated1,798
  • diarrhoea1,763
  • product use in unapproved indication1,763
  • vomiting1,741
  • dizziness1,587
  • arthralgia1,576
  • malaise1,424

Reports by year received

View as table
YearReports
200471
200558
200640
200780
2008116
2009110
2010113
2011177
2012175
2013203
2014253
20152,003
20161,396
20171,355
20181,687
20191,455
20201,650
20211,913
20222,445
20232,871
20243,654
20254,065
20263,402

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,024,867 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
pruritusSignal2,7605.25.09,429
product use in unapproved indicationSignal1,7635.14.95,898
rashSignal2,6074.34.26,734
condition aggravatedSignal1,7984.34.14,531
drug ineffectiveSignal5,2532.92.86,796
arthralgiaSignal1,5762.72.61,752
vomitingSignal1,7412.72.51,844
painSignal2,1872.62.52,136
off label useSignal2,9252.42.32,491
malaiseSignal1,4242.32.21,106
dizzinessSignal1,5872.32.21,175
headacheSignal1,8722.12.11,178
diarrhoea1,7632.01.9857
fatigue2,1132.01.91,014
nausea2,0381.91.8826

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.